Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
National Cancer Institute (NCI),Radiation Therapy Oncology Group
Scientific Title
Randomized Phase III Study of Sorafenib Versus Stereotactic Body Radiation Therapy Followed by Sorafenib in Hepatocellular Carcinoma